Alpha1-proteinase inhibitor (Human, Grifols)

Product Name :
Alpha1-proteinase inhibitor (Human, Grifols)

Search keywords :
alpha 1-Antitrypsin

drugId :
null

Target Vo:
Serine protease

Target Vo Short Name :
Serine protease

Moa_Name:
Serine protease inhibitors

First Approval Country :
United States

First Approval Date Filter:
1987

Origin Company_Name :
Grifols Sa

Active Company_Name :
Grifols Japan Kk

Active Indication_Name:
alpha 1-Antitrypsin Deficiency

In Active Indication_Name:
Cystic Fibrosis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
B-Raf Antibody
BDNF Antibody
phospho-PI3 Kinase p110 beta (Ser1070) Antibody: phospho-PI3 Kinase p110 beta (Ser1070) Antibody is an unconjugated, approximately 110-123 kDa, rabbit-derived, anti-phospho-PI3 Kinase p110 beta (Ser1070) polyclonal antibody. phospho-PI3 Kinase p110 beta (Ser1070) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, guinea pig background without labeling.

Author: Betaine hydrochloride

Related Posts